Ofev Less Beneficial for Patients with Severe IPF

  • Research and Development

    Ofev Less Beneficial for Patients with Severe IPF

    Posted by Pulmonary Fibrosis News Moderator on November 12, 2018 at 7:47 pm

    A recent study found that that treatment with Ofev offers fewer clinical benefits to patients with severe idiopathic pulmonary fibrosis (IPF). Click here to find out more.

    Have you been treated with Ofev? Do you think the severity of your diagnosis impacted its ability to help you?

    replied 7 years ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .